Anzeige
Mehr »
Login
Freitag, 16.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Codename: Siebzehntausend! Rritual landet den "Super-Vertrag"!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14W4W ISIN: SE0007577895 Ticker-Symbol: 6Y4 
Frankfurt
16.04.21
08:02 Uhr
2,300 Euro
-0,085
-3,56 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
VICORE PHARMA HOLDING AB Chart 1 Jahr
5-Tage-Chart
VICORE PHARMA HOLDING AB 5-Tage-Chart

Aktuelle News zur VICORE PHARMA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoVicore Pharma publishes the Annual Report for 2020130GOTHENBURG, Sweden, April 15, 2021 /PRNewswire/ -- Vicore Pharma Holding AB (publ), a pharmaceutical company developing innovative medicines for severe lung disorders such as idiopathic pulmonary...
► Artikel lesen
08.04.Notice of annual general meeting of Vicore Pharma Holding AB (publ)-
VICORE PHARMA Aktie jetzt für 0€ handeln
31.03.VICORE PHARMA HOLDING AB: Increase of number of shares and votes in Vicore Pharma-
11.03.Vicore Pharma's drug candidate C21 dilates peripheral resistance vessels in fibrotic disease179GOTHENBURG, Sweden, March 11, 2021 /PRNewswire/ -- Vicore Pharma Holding AB (publ), a pharmaceutical company developing innovative medicines for severe lung disorders such as idiopathic pulmonary...
► Artikel lesen
05.03.Press release from the extraordinary general meeting of Vicore Pharma Holding AB (publ)1
26.02.VICORE PHARMA HOLDING AB: Increase of number of shares and votes in Vicore Pharma1
26.02.Vicore Pharma Holding AB (publ) publishes the year-end report for 2020220GOTHENBURG, SWEDEN, Feb. 26, 2021 /PRNewswire/ -- Important events during the fourth quarter In October, Vicore announced completion of patient enrollment in the phase II study...
► Artikel lesen
10.02.Notice of extraordinary general meeting of Vicore Pharma Holding AB (publ)1
10.02.VICORE PHARMA HOLDING AB: Vicore Pharma has completed a directed share issue of SEK 336 million1
09.02.Vicore Pharma intends to carry out a directed share issue255GOTHENBURG, Sweden, Feb. 9, 2021 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore Pharma" or the "Company") today announces its intention to carry out a directed share issue corresponding...
► Artikel lesen
09.02.VICORE PHARMA HOLDING AB: Vicore Pharma intends to carry out a directed share issue-
01.02.Positive data from Phase II study ATTRACT in patients with COVID-19 published online: Vicore Pharma Holding167GOTHENBURG, Sweden, Feb. 1, 2021 /PRNewswire/ -- Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders, today published...
► Artikel lesen
01.02.VICORE PHARMA HOLDING AB: Positive data from Phase II study ATTRACT in patients with COVID-19 published online2
23.12.20Vicore Pharma's C21 med shows promise in COVID-19 study1
08.12.20Vicore Pharma reports positive top line data from the ATTRACT clinical study in patients with COVID-19291Oral C21 treatment demonstrates significant clinical improvement on top of corticosteroids GOTHENBURG, Sweden, Dec. 8, 2020 /PRNewswire/ -- Vicore Pharma Holding AB (publ), a pharmaceutical...
► Artikel lesen
08.12.20VICORE PHARMA HOLDING AB: Vicore Pharma reports positive top line data from the ATTRACT clinical study in patients with COVID-192
16.11.20Vicore Pharma recruits the first patient in the phase 2 proof-of-concept study in idiopathic pulmonary fibrosis1
16.11.20Vicore Pharma recruits the first patient in the phase II Proof-of-Concept study in idiopathic pulmonary fibrosis234GOTHENBURG, Sweden, Nov. 16, 2020 /PRNewswire/ -- Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announces...
► Artikel lesen
16.11.20VICORE PHARMA HOLDING AB: Vicore Pharma recruits the first patient in the phase II Proof-of-Concept study in idiopathic pulmonary fibrosis1
06.11.20Vicore Pharma Holding AB (publ) publishes the interim report for the third quarter 2020518GOTHENBURG, Sweden, Nov. 6, 2020 /PRNewswire/ -- Important events during the third quarter In July, Vicore completed a directed share issue resulting in proceeds of 185 MSEK before...
► Artikel lesen
Seite:  Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1